BIO-TECHNE Corp Earnings Per Share Disclosure
Note 9. Earnings Per Share:
The following table reflects the calculation of basic and diluted earnings per share (in thousands, except per share amounts):
| ||||||||||
Year Ended June 30, | ||||||||||
| 2025 |
| 2024 |
| 2023 | |||||
Earnings per share – basic: | ||||||||||
Net earnings, including noncontrolling interest | $ | 73,400 |
| $ | 168,105 |
| $ | 285,442 | ||
Less net earnings attributable to noncontrolling interest | — | — | 179 | |||||||
Net earnings attributable to Bio-Techne | $ | 73,400 | $ | 168,105 | $ | 285,263 | ||||
Income allocated to participating securities |
| (37) |
| (33) |
| (70) | ||||
Income available to common shareholders | $ | 73,363 | $ | 168,072 | $ | 285,193 | ||||
Weighted-average shares outstanding – basic |
| 157,521 |
| 157,708 |
| 157,179 | ||||
Earnings per share – basic | $ | 0.47 | $ | 1.07 | $ | 1.81 | ||||
| ||||||||||
Earnings per share – diluted: |
|
|
|
|
|
| ||||
Net earnings, including noncontrolling interest | $ | 73,400 | $ | 168,105 | $ | 285,442 | ||||
Less net earnings attributable to noncontrolling interest | — | — | 179 | |||||||
Net earnings attributable to Bio-Techne | $ | 73,400 | $ | 168,105 | $ | 285,263 | ||||
Income allocated to participating securities |
| (37) |
| (33) |
| (70) | ||||
Income available to common shareholders | $ | 73,363 | $ | 168,072 | $ | 285,193 | ||||
Weighted-average shares outstanding – basic |
| 157,521 |
| 157,708 |
| 157,179 | ||||
Dilutive effect of stock options and restricted stock units |
| 2,196 |
| 3,066 |
| 4,676 | ||||
Weighted-average common shares outstanding – diluted |
| 159,717 |
| 160,774 |
| 161,855 | ||||
Earnings per share – diluted | $ | 0.46 | $ | 1.05 | $ | 1.76 | ||||
Basic net income per common share is calculated based on the weighted average number of common shares outstanding during the period. Diluted net income per common share is computed by dividing net income by the weighted average number of common and potentially dilutive common shares outstanding during the period. Potentially dilutive common shares of our stock result from dilutive common stock options and restricted stock units. We use the treasury stock method to calculate the weighted-average shares used in the diluted earnings per share computation. Under the treasury stock method, the proceeds from exercise of an option, the amount of compensation cost, if any, for future service that we have not yet recognized, and the amount of estimated tax benefits that would be recorded in paid-in capital, if any, when the option is exercised are assumed to be used to repurchase shares in the current period.
The dilutive effect of stock options in the above table excludes all options for which the aggregate exercise proceeds exceeded the average market price for the period. The number of potentially dilutive option shares excluded from the calculation was 3.8 million, 3.9 million, and 4.5 million for fiscal 2025, 2024 and 2023, respectively.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Aug 22, 2025 | Showing above |
| 2024 | Aug 22, 2024 | |
| 2023 | Aug 23, 2023 | |
| 2022 | Aug 24, 2022 | |
| 2021 | Aug 25, 2021 | |
| 2020 | Aug 26, 2020 | |
| 2019 | Aug 28, 2019 | |
| 2018 | Aug 27, 2018 | |
| 2017 | Sep 7, 2017 | |
| 2016 | Aug 29, 2016 | |
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.